Medications

Drug boosts survival for women with advanced ovarian cancer

Women with advanced ovarian cancer often face grim statistics, with less than half surviving for five years after their diagnosis. However, a new study suggests that so-called "maintenance therapy" with a targeted cancer ...

Oncology & Cancer

Study shows ovarian cancer survival increase

A gynecologic oncologist at the Stephenson Cancer Center at OU Medicine was a national leader of a newly published research study that reveals good news for women with ovarian cancer—longer survival times plus a treatment ...

Oncology & Cancer

New screening strategy may catch ovarian cancer at early stages

Evaluating its change over time, CA-125, the protein long-recognized for predicting ovarian cancer recurrence, now shows promise as a screening tool for early-stage disease, according to researchers at The University of Texas ...

Oncology & Cancer

Chemoresponse assay helps boost ovarian cancer survival

This spring, a team of researchers has released results from an eight-year study that shows improved survival rates for women diagnosed with ovarian cancer who undergo cancer tumor testing to determine the best treatment.

page 1 from 2